跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

1453526

USP

Naltrexone Related Compound A

United States Pharmacopeia (USP) Reference Standard

登录查看公司和协议定价

别名:
(5α)-17-(3-Butenyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride, N-(3-Butenyl)noroxymorphone hydrochloride, NIH 10458
经验公式(希尔记法):
C20H23NO4 · HCl
分子量:
377.86
UNSPSC代码:
41116107
NACRES:
NA.24

等级

pharmaceutical primary standard

API类

naltrexone

制造商/商品名称

USP

药品控制

USDEA Schedule II; regulated under CDSA - not available from Sigma-Aldrich Canada

应用

pharmaceutical (small molecule)

格式

neat

InChI

1S/C20H23NO4.ClH/c1-2-3-9-21-10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12;/h2,4-5,15,18,22,24H,1,3,6-11H2;1H/t15-,18+,19+,20-;/m1./s1

InChI key

UMLGCEOOYPDDJJ-ITLPAZOVSA-N

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Naltrexone Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

Sales restrictions may apply.

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral - STOT SE 3

靶器官

Central nervous system

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

监管及禁止进口产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门